MedTrace Logo

Prevention of Adverse Pregnancy Outcome With Vitamin D Supplementation During Pregnancy

NCT01418664 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 172

Last updated 2016-04-25

No results posted yet for this study

Summary

We hypothesized that vitamin D supplementation during pregnancy can prevent adverse pregnancy outcome.

Conditions

  • Pregnancy

Interventions

DIETARY_SUPPLEMENT

D Max drops

Women in study arm will be cases, and will recieve ferrous sulphate and calcium lactate, along with 4000IU D Max drops

Sponsors & Collaborators

  • Yale University

    collaborator OTHER

  • Dow University of Health Sciences

    lead OTHER

Principal Investigators

  • Nazli Hossain, MBBS, FCPS · Dow University of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2012-05-31
Completion
2012-05-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01418664 on ClinicalTrials.gov